Search results for "Osteoporosis"


 
Results 1 - 10 of about 144 for "Osteoporosis".
Sort by: Relevance | Newest | Oldest

First NASH treatment, over-the-counter CGM approved

This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2024/05/first-nash-treatment-over-the-counter-cgm-approved.htm
1 May 2024

MKSAP Quiz: Evaluation after a fall and surgery

A 72-year-old man is evaluated following surgical fixation of a right distal radius fracture after a fall. A dual-energy x-ray absorptiometry scan performed 2 years ago showed low bone mineral density. Alendronate weekly was initiated after the scan, and he has been adherent to therapy. What is the most appropriate management?
https://immattersacp.org/weekly/archives/2024/04/30/3.htm
30 Apr 2024

Treat COPD symptoms, solve problems

Effectively managing chronic obstructive pulmonary disease means staying up to date on medications, devices, and delivery techniques.
https://immattersacp.org/archives/2024/04/treat-copd-symptoms-solve-problems.htm
1 Apr 2024

Antifracture effects of zoledronate persist for up to 3.5 years, study suggests

Fracture rates rose from 15 per 1,000 woman-years in the last two years of a six-year trial to 24 fractures in the first two years of follow-up. In the next two years of follow-up, the rate substantially increased to 42 fractures per 1,000 woman-years.
https://immattersacp.org/weekly/archives/2024/03/12/4.htm
12 Mar 2024

CPAP masks with magnets recalled

This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2024/03/cpap-masks-with-magnets-recalled.htm
1 Mar 2024

Testosterone may not decrease fracture risk in hypogonadism

A substudy of an industry-funded randomized trial in men with hypogonadism found that 3.50% of those assigned to testosterone and 2.46% assigned to placebo had a clinical fracture after 3.19 years of follow-up.
https://immattersacp.org/weekly/archives/2024/01/23/2.htm
23 Jan 2024

Latest updates on ACP's priorities, initiatives

ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2023/11/latest-updates-on-acps-priorities-initiatives.htm
1 Nov 2023

New ACP paper reviews performance measures for osteoporosis

Of the six osteoporosis performance measures relevant to internal medicine physicians, only one is valid at three levels of attribution, i.e., individual physician, group practice, and health plan, an ACP assessment found.
https://immattersacp.org/weekly/archives/2023/10/10/6.htm
10 Oct 2023

OTC birth control pill, naloxone gain approval

This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2023/09/otc-birth-control-pill-naloxone-gain-approval.htm
1 Sep 2023

Cardiovascular effects of vitamin D supplementation still uncertain, trial finds

Older adults who were randomized to vitamin D supplementation had a slightly lower rate of cardiovascular events, particularly myocardial infarction, but the overall difference from placebo was not significant, an Australian trial found.
https://immattersacp.org/weekly/archives/2023/07/04/4.htm
4 Jul 2023

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next